Yeah, here is an old post copied here of my rough
Post# of 146342
https://investorshangout.com/post/view?id=5596806
Link to cancers and ccr5 in previous post I replied to here, just rough estimating,
Quote:
Metastasis is believed to be the cause of up to 90 percent of cancer deaths.
https://www.sciencedaily.com/releases/2019/05...112734.htm
Also depending on cancer, looks like 25%-75% can be high ccr5 expressing, from these links, so say 50%.
US deaths 352k per year from these, see below
352k cancer deaths x 90% death from metastasis x 50% ccr5+ in metastatic
gives
160k deaths per year which leronlimab might help save or extend life for a good number of these in US alone. I know we just have data on the one patient, but the possibilities here with this is truly amazing.
Of course if it works for a percentage these 160k, they wont stop there, it will probably be moved to earlier stages.
pancreatic, prostate, lung, breast, liver and melanoma cancers
1) Breast Cancer New Cases: 271k Deaths: 42k
2) Lung New Cases: 228k Deaths: 143k
3) Prostate New Cases: 175k Deaths: 32k
4)Colorectal New Cases: 146k Deaths: 51k
5) Melanoma New Cases: 96k Deaths: 7k
11) Pancreatic New Cases: 57k Deaths: 46k
13) LiverNew Cases: 42k Deaths: 31k
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)